The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study. | Synapse
March 3, 2026
The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study.
Key Points
This research examines the association between the C-reactive protein-triglyceride glucose index and the risk of developing chronic diseases.
Conducted a longitudinal cohort study
Monitored participants for new-onset chronic diseases
Analyzed the relationship between CTI, chronic disease onset, and clinical outcomes
Elevated CTI is linked to a higher risk of chronic diseases
Significant predictive value of CTI as a biomarker
CTI may serve as a valuable tool in clinical risk assessment
Abstract
Elevated CTI is strongly associated with an increased risk of several chronic diseases, highlighting its potential value as a clinical risk assessment tool and predictive biomarker.